HYDROCODONE
- CAS No.
- 125-29-1
- Chemical Name:
- HYDROCODONE
- Synonyms
- Dico;50-100g;Bekadid;Dicodid;Codinovo;Hydrocone;Multacodin;Hydrocodon;HYDROCODONE;Dihydrocodeinone
- CBNumber:
- CB3145249
- Molecular Formula:
- C18H21NO3
- Molecular Weight:
- 299.37
- MOL File:
- 125-29-1.mol
- Modify Date:
- 2023/6/8 9:03:07
| Melting point | 194-197°C |
|---|---|
| Boiling point | 440.69°C (rough estimate) |
| Density | 1.1613 (rough estimate) |
| refractive index | 1.5500 (estimate) |
| Flash point | 9℃ |
| storage temp. | Controlled Substance, -20°C Freezer |
| solubility | Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | pKa 6.61(50% aq EtOH) (Uncertain) |
| color | Prisms from EtOH |
| EPA Substance Registry System | Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.)- (125-29-1) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |    GHS02,GHS06,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H301+H311+H331-H370 | |||||||||
| Precautionary statements | P210-P260-P280-P301+P310-P311 | |||||||||
| Hazard Codes | F,T | |||||||||
| Risk Statements | 11-23/24/25-39/23/24/25 | |||||||||
| Safety Statements | 16-36/37-45 | |||||||||
| RIDADR | 1544 | |||||||||
| WGK Germany | 1 | |||||||||
| HazardClass | 6.1(b) | |||||||||
| PackingGroup | III | |||||||||
| HS Code | 2939110000 | |||||||||
| Toxicity | LD50 s.c. in mice: 85.7 mg/kg (Eddy, Reid) | |||||||||
| NFPA 704 |
|
HYDROCODONE Chemical Properties,Uses,Production
Chemical Properties
Beige Solid
Uses
Hydrocodone is a powerful anticough drug that is widely used for suppressing the cough reflex. It is widely used in effective commercial anticough drugs in combination with guaiphenesin (entuss), with homatropine (hycodan), with phenylpropanolamine (hycomine), phenyltoloxamine (tussionex), and pseudoephedrine and guaiphenesin (tussened).
Definition
ChEBI: A morphinane-like compound that is a semi-synthetic opioid synthesized from codeine.
General Description
Hydrocodone is the 3 methoxy version of hydromorphone.The loss of the 3-OH group yields a compound that is approximately4 to 5 times less potent than hydromorphone, thusabout equal to morphine. Unlike codeine, the agonist activityof hydrocodone does not require 3-O-demethylation, althoughit does occur via CYP2D6 representing 4.6% of totalclearance. The protected 3-position has better brain penetration,and the 7,8-dihydro-6-keto C ring contributes to the increasedbinding of the compound to the μ-receptor.
There are no pure hydrocodone products available on theU.S. market. All FDA-approved products containing hydrocodoneare combination products. Like codeine, hydrocodoneis marketed as an antitussive agent. It is availablecombined with the anticholinergic agent homatropineas a syrup and a tablet. The addition of the anticholinergicagent is to discourage abuse. It is also available in a delayedrelease suspension form (Tussionex). This formulation usesa sulfonated styrene divinylbenzene copolymer complexedwith hydromorphone and chlorpheniramine that acts as acation-exchange resin slowly releasing the drugs over a 12-hour period. Hydrocodone is also marketed in combinationwith acetaminophen (Vicodin, Lortab) or aspirin (LortabASA) for the treatment of pain. The dose of acetaminophenconsumed by the patient must be closely monitored, andprescriptions that allow for greater than 4 grams of acetaminophenper 24-hour period should not be dispensed.
Safety Profile
Poison by intravenous and subcutaneous routes. When heated to decomposition it emits toxic fumes of NOx.
HYDROCODONE Preparation Products And Raw materials
Raw materials
1of2
chevron_rightPreparation Products
125-29-1(HYDROCODONE)Related Search:
1of4
chevron_right